The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Molecure S.A.
+ business areaBioPharma R&D+Services
2020 – 124,910,000 PLN
2021 – 1,170,000 PLN
2022 – 7,510,000 PLN
2023 – 3,650,000 PLN
2024 – 2,920,000 PLN
2020 – 84
2021 – 89
2022 – 107
2023 – 111
2024 – 102
2020 – 218,000 PLN
2021 – 300,000 PLN
2022 – 1,313,000 PLN
2023 – 2,826,000 PLN
2024 – 3,820,000 PLN
Molecure S.A., listed on the Warsaw Stock Exchange, is a clinical-stage biotechnology company developing first-in-class small molecule drugs targeting underexplored proteins and RNA functions for cancer and inflammatory diseases. Its pipeline includes OATD-01, a dual chitinase inhibitor in Phase II for interstitial lung diseases, and OATD-02, a dual arginase inhibitor in Phase I for oncology, supported by collaborations with leading global research institutions.